Tuesday, June 12, 2018 4:13:04 AM
D
“Ryan
May 9th, 2018
Exclusive, News, Top News
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While there are over 100 licensed producers planning to have over 700,000 kilograms of production capacity online by the end of the year, Marijuana Policy Group estimates that demand could exceed 900,000 kilograms and there could be a shortfall in supply.
Investors looking to capitalize on these supply and demand economics have many options, but the best opportunities are companies with strong management teams focused on a niche market that won’t be eroded by the commoditization of the industry over time.
RavenQuest BioMed Inc. (CSE: RQB) began as a management and consulting firm that helped nearly 60 clients become licensed producers of medical cannabis under Health Canada’s ACMPR program. After taking the time to understand their problems, the company partnered with McGill University and began researching technology solutions and began pursuing partnerships that leverage its public company status to finance projects.
CFN Media recently sat down with CEO George Robinson to discuss the company’s approach to the market and why investors may want to take note:”
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM